Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Heartware International Inc. (“Heartware” or the “Company”) (NasdaqGS: HTWR -News). Such investors are advised to contact Peretz Bronstein or his investor relations coordinator Eitan Kimelman at [email protected] or 212-697-6484.
The investigation concerns whether Heartware and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On September 9, 2015, HeartWare disclosed that it had paused its MVAD clinical trial to address an MVAD controller manufacturing process issue. Then, on October 13, 2015, HeartWare announced that following the company’s investigation of causes of reported adverse effects in certain clinical trial patients, HeartWare might not re-initiate enrollment in the MVAD clinical trial in November as it had previously planned.
Following this news, shares of Heartware fell $7.21 or 16.38%, during intraday trading to trade at $36.82 on October 13, 2015.
If you are aware of any facts relating to this investigation, or purchased shares of Heartware, you can assist this investigation by contacting Peretz Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email [email protected]. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
[email protected]
The post Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Heartware International Inc. appeared first on Live Trading News.